Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FZD5 is a cell surface receptor for Wnt signaling proteins, acting as the primary receptor for ligands such as WNT3A, WNT5A, WNT7A, and WNT10B. It activates both canonical (β-catenin-dependent) and non-canonical pathways. FZD5 plays critical roles during embryonic development and adult tissue homeostasis, and its dysregulation has been implicated in several cancers and neurodegenerative diseases.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Frizzled class receptor 5 (FZD5).